Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

The landscape of thromboprophylaxis utilization in critically ill children: sparse and variable.

Gist KM, Chima RS.

Crit Care Med. 2014 May;42(5):1317-8. doi: 10.1097/CCM.0000000000000185. No abstract available.

PMID:
24736356
2.

A multinational study of thromboprophylaxis practice in critically ill children.

Faustino EV, Hanson S, Spinella PC, Tucci M, O'Brien SH, Nunez AR, Yung M, Truemper E, Qin L, Li S, Marohn K, Randolph AG; PROphylaxis against ThRombosis prACTice (PROTRACT) Study Investigators of the PALISI BloodNet.

Crit Care Med. 2014 May;42(5):1232-40. doi: 10.1097/CCM.0000000000000147.

3.

Time to recommend heparin and low-molecular-weight heparins in thromboprophylaxis in medical-surgical critically ill patients.

Volpi N.

Crit Care Med. 2013 Sep;41(9):2224-6. doi: 10.1097/CCM.0b013e31828fd852. No abstract available.

PMID:
23979368
4.

Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials.

Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ.

Crit Care Med. 2013 Sep;41(9):2088-98. doi: 10.1097/CCM.0b013e31828cf104. Review.

PMID:
23782973
5.

Is low-molecular-weight heparin useful for venovenous hemofiltration in the intensive care unit?

Spiegel DM, Anderson RJ.

Crit Care Med. 1999 Oct;27(10):2316-7. Review. No abstract available.

PMID:
10548241
6.

DVT prevention. Low-molecular-weight heparin is a viable option.

Benton L.

Am J Nurs. 2000 Feb;100(2):84. No abstract available.

PMID:
10712165
7.

Dalteparin in critically ill patients.

Esterbrook G, Hart S.

N Engl J Med. 2011 Jul 14;365(2):179; author reply 180. doi: 10.1056/NEJMc1105423#SA1. No abstract available.

PMID:
21751920
8.

Dalteparin versus unfractionated heparin in critically ill patients.

PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group, Cook D, Meade M, Guyatt G, Walter S, Heels-Ansdell D, Warkentin TE, Zytaruk N, Crowther M, Geerts W, Cooper DJ, Vallance S, Qushmaq I, Rocha M, Berwanger O, Vlahakis NE.

N Engl J Med. 2011 Apr 7;364(14):1305-14. doi: 10.1056/NEJMoa1014475. Epub 2011 Mar 22.

9.

Dalteparin in critically ill patients.

Smythe MA, Koerber JM.

N Engl J Med. 2011 Jul 14;365(2):179-80; author reply 180. doi: 10.1056/NEJMc1105423#SA2. No abstract available.

PMID:
21751919
10.

Dalteparin and heparin-induced thrombocytopenia.

Davidson BL.

N Engl J Med. 2011 Sep 22;365(12):1158; author reply 1158. doi: 10.1056/NEJMc1108392#SA1. No abstract available.

PMID:
21992138
11.

Venous thromboembolism prophylaxis in critically ill patients.

McLeod AG, Geerts W.

Crit Care Clin. 2011 Oct;27(4):765-80, v. doi: 10.1016/j.ccc.2011.07.001. Epub 2011 Sep 13. Review.

PMID:
22082513
12.

Risk assessment and prophylaxis of venous thromboembolism in acutely and/or critically ill patients.

Davidson BL.

Haemostasis. 2000;30 Suppl 2:77-81; discussion 63. Review.

PMID:
11251346
13.

Aspirin for lower limb arthroplasty thromboprophylaxis: review of international guidelines.

Donohoe CL, Sayana MK, Thakral R, Niall DM.

Ir J Med Sci. 2011 Sep;180(3):627-32. doi: 10.1007/s11845-010-0658-0. Epub 2010 Dec 14. Review.

PMID:
21286842
14.

Thromboprophylaxis for patients at high risk of VTE.

Lowe G.

Lancet. 2008 Sep 20;372(9643):1037-8. doi: 10.1016/S0140-6736(08)61442-7. No abstract available.

PMID:
18805329
15.

Thromboprophylaxis in arthroscopic surgery.

Anand A.

Arthroscopy. 2014 Jul;30(7):780. doi: 10.1016/j.arthro.2014.04.094. No abstract available.

PMID:
24951355
16.
17.

Newer anticoagulants in critically ill patients.

Rajasekhar A, Beyth R, Crowther MA.

Crit Care Clin. 2012 Jul;28(3):427-51, vii. doi: 10.1016/j.ccc.2012.04.005. Review.

PMID:
22713616
18.

Thromboprophylaxis in medical-surgical critically ill patients.

Crowther MA, Cook DJ.

Curr Opin Crit Care. 2008 Oct;14(5):520-3. doi: 10.1097/MCC.0b013e32830c484d. Review.

PMID:
18787443
19.

An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN.

Schellong SM, Haas S, Greinacher A, Schwanebeck U, Sieder C, Abletshauser C, Bramlage P, Riess H.

Expert Opin Pharmacother. 2010 Dec;11(18):2953-61. doi: 10.1517/14656566.2010.521498. Epub 2010 Oct 18.

PMID:
20950224
20.

Thromboprophylaxis in immobilized medical patients.

Vaitkus PT.

Eur J Med Res. 2004 Mar 30;9(3):131-4. Review.

PMID:
15096323

Supplemental Content

Support Center